MLchartDataset catalogue

copper Cu 64 NOTA-PSMAi-PEG-Cy5.5-C' dots

Term · Oncology and biomedicine · MLC-T-ONC-012748

An imaging agent composed of silica-based nanoparticles labeled with a near-infrared (NIR) fluorophore, cyanine 5.5 (Cy5.5), and surrounded by polyethylene glycol (PEG) chains attached to a human prostate-specific membrane antigen (PSMA) inhibitor (PSMAi) and labeled with, via the macrocyclic chelating agent 1,4,7-triazacyclononane-N,N',N''-triacetic acid (NOTA), the radioisotope copper Cu 64, with potential tumor-selective diagnostic properties upon positron emission tomography (PET) imaging. Upon administration of the copper Cu 64 NOTA-PSMAi-PEG-Cy5.5-C' dots, the PSMAi moiety selectively targets and binds to PSMA expressed on tumor cells. Upon PET imaging, PSMA-expressing tumor cells can be visualized and assessed. PSMA, a tumor-associated antigen (TAA) and type II transmembrane protein, is expressed on the membrane of prostatic epithelial cells and overexpressed on prostate tumor cells. The nanoparticle formulation may allow for enhanced uptake in PSMA-positive tumors.

Table 1. Record
IdentifierMLC-T-ONC-012748
FieldOncology and biomedicine
Synonyms64Cu-NOTA-PSMA-PEG-Cy5.5-C' dot tracer; (64Cu)-labeled PSMA-targeting -PEG Cy5.5-C' dots; 64Cu-NOTA-PSMAi-PEG-Cy5.5-C' dots; 64Cu-NOTA-PSMA-PEG-Cy5.5-C' dots
ReferencesNational Cancer Institute Thesaurus (CC BY 4.0)
Record as JSON
{
  "id": "MLC-T-ONC-012748",
  "term": "copper Cu 64 NOTA-PSMAi-PEG-Cy5.5-C' dots",
  "field": "Oncology and biomedicine",
  "definition": "An imaging agent composed of silica-based nanoparticles labeled with a near-infrared (NIR) fluorophore, cyanine 5.5 (Cy5.5), and surrounded by polyethylene glycol (PEG) chains attached to a human prostate-specific membrane antigen (PSMA) inhibitor (PSMAi) and labeled with, via the macrocyclic chelating agent 1,4,7-triazacyclononane-N,N',N''-triacetic acid (NOTA), the radioisotope copper Cu 64, with potential tumor-selective diagnostic properties upon positron emission tomography (PET) imaging. Upon administration of the copper Cu 64 NOTA-PSMAi-PEG-Cy5.5-C' dots, the PSMAi moiety selectively targets and binds to PSMA expressed on tumor cells. Upon PET imaging, PSMA-expressing tumor cells can be visualized and assessed. PSMA, a tumor-associated antigen (TAA) and type II transmembrane protein, is expressed on the membrane of prostatic epithelial cells and overexpressed on prostate tumor cells. The nanoparticle formulation may allow for enhanced uptake in PSMA-positive tumors.",
  "synonyms": [
    "64Cu-NOTA-PSMA-PEG-Cy5.5-C' dot tracer",
    "(64Cu)-labeled PSMA-targeting -PEG Cy5.5-C' dots",
    "64Cu-NOTA-PSMAi-PEG-Cy5.5-C' dots",
    "64Cu-NOTA-PSMA-PEG-Cy5.5-C' dots"
  ],
  "references": [
    "National Cancer Institute Thesaurus"
  ],
  "url": "https://mlchart.com/terminology/oncology/copper-cu-64-nota-psmai-peg-cy5-5-c-dots/"
}

Record 5,298 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.